Evidence map›Paper›PMID 26544686›Full record

ArticlePLoS neglected tropical diseases2015

siRNA-Mediated Silencing of doublesex during Female Development of the Dengue Vector Mosquito Aedes aegypti.

Keshava Mysore, Longhua Sun, Michael Tomchaney, Gwyneth Sullivan, Haley Adams, Andres S Piscoya, David W Severson, Zainulabeuddin Syed, Molly Duman-Scheel

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Challenges of Robust RNAi-Mediated Gene Silencing inInternational journal of molecular sciences · 2024
    Article
  6. Article
  7. Article
  8. Targeting Sex Determination to Suppress Mosquito Populations.bioRxiv : the preprint server for biology · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. A Conserved Female-Specific Requirement for thePathogens (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Keshava MysoreDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, South Bend, Indiana, United States of America.
Longhua SunEck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, United States of America.
Michael TomchaneyDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, South Bend, Indiana, United States of America.
Gwyneth SullivanEck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, United States of America.
Haley AdamsDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, South Bend, Indiana, United States of America.
Andres S PiscoyaDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, South Bend, Indiana, United States of America.
David W SeversonDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, South Bend, Indiana, United States of America.
Zainulabeuddin SyedEck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, United States of America.
Molly Duman-ScheelDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, South Bend, Indiana, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of sex-specific traits, including the female-specific ability to bite humans and vector disease, is critical for vector mosquito reproduction and pathogen transmission. Doublesex (Dsx), a terminal transcription factor in the sex determination pathway, is known to regulate sex-specific gene expression during development of the dengue fever vector mosquito Aedes aegypti. Here, the effects of developmental siRNA-mediated dsx silencing were assessed in adult females. Targeting of dsx during A. aegypti development resulted in decreased female wing size, a correlate for body size, which is typically larger in females. siRNA-mediated targeting of dsx also resulted in decreased length of the adult female proboscis. Although dsx silencing did not impact female membrane blood feeding or mating behavior in the laboratory, decreased fecundity and fertility correlated with decreased ovary length, ovariole length, and ovariole number in dsx knockdown females. Dsx silencing also resulted in disruption of olfactory system development, as evidenced by reduced length of the female antenna and maxillary palp and the sensilla present on these structures, as well as disrupted odorant receptor expression. Female lifespan, a critical component of the ability of A. aegypti to transmit pathogens, was also significantly reduced in adult females following developmental targeting of dsx. The results of this investigation demonstrate that silencing of dsx during A. aegypti development disrupts multiple sex-specific morphological, physiological, and behavioral traits of adult females, a number of which are directly or indirectly linked to mosquito reproduction and pathogen transmission. Moreover, the olfactory phenotypes observed connect Dsx to development of the olfactory system, suggesting that A. aegypti will be an excellent system in which to further assess the developmental genetics of sex-specific chemosensation.

Indexed as

Gene Expression Regulation, DevelopmentalSex CharacteristicsSex DifferentiationAedesAnimalsFeeding BehaviorFemaleGene SilencingInsect ProteinsInsect VectorsRNA, Small InterferingSexual Behavior, AnimalInsect ProteinsRNA, Small Interfering

Identifiers

PMID26544686
PMCPMC4636264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.